Breaking News Instant updates and real-time market news.

XPER

Xperi

$12.80

-0.53 (-3.98%)

, SSNLF

Samsung

$0.00

(0.00%)

08:04
12/10/18
12/10
08:04
12/10/18
08:04

Xperi announces settlement, new patent license agreement with Samsung

Xperi (XPER) announced that it has reached an agreement with Samsung Electronics (SSNLF) to settle and dismiss all pending litigation between the companies. In connection with the settlement, the companies have entered into a new patent license agreement. The terms and conditions of the agreement are confidential.

XPER

Xperi

$12.80

-0.53 (-3.98%)

SSNLF

Samsung

$0.00

(0.00%)

  • 12

    Dec

  • 06

    Jan

XPER Xperi
$12.80

-0.53 (-3.98%)

11/08/18
CHLM
11/08/18
NO CHANGE
Target $20
CHLM
Buy
Xperi price target lowered to $20 from $25 at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for Xperi to $20 from $25 following quarterly results. The analyst reiterates a Buy rating on the shares.
11/08/18
BNCH
11/08/18
NO CHANGE
Target $25
BNCH
Buy
Xperi shares look 'ridiculously cheap,' says Benchmark
Benchmark analyst Gary Mobley reiterated his Buy rating on Xperi shares and called the stock "ridiculously cheap" following the company's better than expected Q3 results and in-line Q4 guidance. However, given the uncertainty if Samsung will renew or not, he lowered his price target on Xperi shares to $25 from $40, stating that he will revisit his estimates and target "when and if Samsung is renewed." Mobley keeps a Buy rating on Xperi.
09/06/18
09/06/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Rite Aid (RAD) reinstated with a Sell at Goldman Sachs. 2. Parker-Hannifin (PH) initiated with an Overweight at Barclays. 3. iRhythm (IRTC) initiated with a Buy at Chardan. 4. Sarepta (SRPT) initiated with an Outperform at Credit Suisse. 5. Xperi (XPER) initiated with a Buy at National Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/18
NATL
09/06/18
INITIATION
Target $31
NATL
Buy
Xperi initiated with a Buy at National Securities
National Securities analyst Matthew Galinko initiated Xperi with a Buy and $31 price target telling investors valuation implies an overly pessimistic view for the IP business and would require a nearly complete failure of the business to rationalize today's valuation. Galinko said this scenario is improbable given Xperi's existing licenses, history of successful assertion processes, and attractive next-gen semiconductor packing technology. The analyst views Xperi's technology assets as compelling and due for significant adoption beginning in 2020.
SSNLF Samsung
$0.00

(0.00%)

11/26/18
RBCM
11/26/18
NO CHANGE
Target $29
RBCM
Outperform
HP executing well, positioned to report in-line Q4, says RBC Capital
RBC Capital analyst Amit Daryanani kept his Outperform rating and $29 price target on HP Inc (HPQ) ahead of its earnings this week, saying the company is positioned to report inline result for Q4 as it continues to execute well. The analyst notes that the stock offers a 10% free cash flow yield and could see some multiple expansion from better organic earnings growth, even though the company is contending with FX related headwinds, lower memory pricing trends, and the declining pace of install base at Samsung (SSNLF) in printing.
11/02/18
NEED
11/02/18
NO CHANGE
Target $125
NEED
Buy
Universal Display price target lowered to $125 from $145 at Needham
Needham analyst James Ricchiuti lowered his price target on Universal Display (OLED) to $125 after its Q3 results and implied guidance suggesting a sequential revenue decline in Q4 of up to 9%. The analyst cites the management's discussion of weaker recovery in materials revenue amid weakness in the smartphone market and the complications from ASC606 standard magnifying changes in the impact of license revenue by a customer such as Samsung (SSNLF). Ricchiuti keeps his Buy rating on Universal Display, saying that the expected decline in the stock price today will bring its risk-reward to "particularly attractive" levels based on the company's 2019 growth expectations.
10/10/18
BFIN
10/10/18
NO CHANGE
BFIN
BlueFin checks show Lumentum received increased orders from Apple
BlueFin analysts John Donovan and Steve Mullane say their firm's latest supply chain checks suggest "strong and stable" iPhone demand. While unit demand has not changed, the mix to higher storage models has increased, which should benefit Toshiba (TOSBF), Samsung (SSNLF), and Micron Technology (MU), Donovan and Mullane tell investors in a research note. Further, BlueFin's latest checks reveal Lumentum (LITE) has received increased orders recently while competitors II-VI (IIVI) and Finisar (FNSR) continue to focus on securing second-source positioning. The latest on the two latter companies is mixed, but overall "encouraging," the analysts contend. As far as the rumors that Apple is exploring internal VCSEL development, they believe this is "more of a negotiating tactic at this point." VCSEL demand "looks to be skyrocketing" and the frustration in developing a secure second-source has likely caused Apple to explore internal development, write Donovan and Mullane. They understand Apple has looked into fabs in Taiwan to see about VCSEL development but note the earliest this could materialize is 2020-2021. This is likely more of a "call to arms" by Apple for Finisar, II-VI, and Lumentum to increase production to meet the demand, "or else face the consequences."
09/25/18
MKMP
09/25/18
NO CHANGE
Target $7.5
MKMP
Buy
Nokia gaining 5G market share with AT&T, says MKM Partners
MKM Partners analyst Michael Genovese kept his Buy rating and $7.50 price target on Nokia (NOK), saying his checks indicate that the company has "gained significant 5G base station market share at AT&T (T) at Ericsson's (ERIC) expense". The analyst notes that while 4G/LTE market share at AT&T was 65% Ericsson and 35% Nokia, the 5G Wireless Access infrastructure market share is likely at 65% Nokia and 35% Samsung (SSNLF). Genovese sees Nokia becoming the "prime infrastructure vendor" heading into 2019 - the year of "major positive global inflection for 5G".

TODAY'S FREE FLY STORIES

VRRM

Verra Mobility

$14.70

0.045 (0.31%)

17:24
11/13/19
11/13
17:24
11/13/19
17:24
Syndicate
Verra Mobility files to sell 15M shares of Class A common stock for holders »

Morgan Stanley is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

EQ

Equillium

$3.20

-0.19 (-5.60%)

17:22
11/13/19
11/13
17:22
11/13/19
17:22
Syndicate
Breaking Syndicate news story on Equillium »

Equillium files $250M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PAG

Penske Automotive

$51.36

0.015 (0.03%)

17:13
11/13/19
11/13
17:13
11/13/19
17:13
Syndicate
Breaking Syndicate news story on Penske Automotive »

Penske Automotive files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LLY

Eli Lilly

$112.85

-0.31 (-0.27%)

17:12
11/13/19
11/13
17:12
11/13/19
17:12
Hot Stocks
FDA committee says benefits of empagliflozin do not outweigh risks »

The FDA Endocrinologic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

PRTH

Priority Technology

$3.24

-0.03 (-0.92%)

17:08
11/13/19
11/13
17:08
11/13/19
17:08
Earnings
Priority Technology reports Q3 EPS (9c), one estimate (12c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$279.24

1.185 (0.43%)

17:07
11/13/19
11/13
17:07
11/13/19
17:07
Hot Stocks
Domino's Pizza's Goldman sells 2,486 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 11

    Dec

  • 12

    Dec

WE

We Company

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

17:04
11/13/19
11/13
17:04
11/13/19
17:04
Periodicals
WeWork reported $1.25B loss in Q3, NY Times reports »

WeWork (WE) lost $1.25B…

WE

We Company

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLYC

GlycoMimetics

$6.27

0.31 (5.20%)

17:02
11/13/19
11/13
17:02
11/13/19
17:02
Initiation
GlycoMimetics initiated  »

GlycoMimetics resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$485.67

-1.24 (-0.25%)

17:00
11/13/19
11/13
17:00
11/13/19
17:00
Hot Stocks
BlackRock CFO sells nearly 4,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ARVN

Arvinas

$28.35

1.85 (6.98%)

16:58
11/13/19
11/13
16:58
11/13/19
16:58
Initiation
Arvinas initiated  »

Arvinas initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FEYE

FireEye

$17.09

-0.04 (-0.23%)

16:57
11/13/19
11/13
16:57
11/13/19
16:57
Recommendations
FireEye analyst commentary  »

FireEye unique offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

CSCO

Cisco

$48.44

0.06 (0.12%)

16:54
11/13/19
11/13
16:54
11/13/19
16:54
Hot Stocks
Cisco says cyber security is a top priority for customers »

Says innovation pipeline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 09

    Dec

  • 10

    Dec

JPM

JPMorgan

$128.49

-0.65 (-0.50%)

16:54
11/13/19
11/13
16:54
11/13/19
16:54
Periodicals
JPMorgan's new HQ plan clears path for another NYC tower, Bloomberg says »

JPMorgan's plan to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 14

    Jan

SIBN

SI-Bone

$17.88

0.14 (0.79%)

16:53
11/13/19
11/13
16:53
11/13/19
16:53
Syndicate
Breaking Syndicate news story on SI-Bone »

SI-Bone files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLI

RLI Corp.

$97.43

0.78 (0.81%)

16:52
11/13/19
11/13
16:52
11/13/19
16:52
Hot Stocks
RLI Corp. declares special cash dividend of $1.00 per share »

Payable on December 20 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CPA

Copa Holdings

$107.71

1.89 (1.79%)

16:52
11/13/19
11/13
16:52
11/13/19
16:52
Hot Stocks
Copa Holdings reports Q3 load factor up 1.4pts to 85.6% »

Copa Holdings reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

XBIT

XBiotech

$11.42

0.18 (1.60%)

16:50
11/13/19
11/13
16:50
11/13/19
16:50
Recommendations
XBiotech analyst commentary  »

XBiotech price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOBC

American Outdoor Brands

$7.90

0.22 (2.86%)

16:50
11/13/19
11/13
16:50
11/13/19
16:50
Hot Stocks
Breaking Hot Stocks news story on American Outdoor Brands »

American Outdoor Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPA

Copa Holdings

$107.71

1.89 (1.79%)

16:48
11/13/19
11/13
16:48
11/13/19
16:48
Earnings
Copa Holdings reports Q3 EPS $2.45, consensus $2.23 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

IDXG

Interpace Diagnostics

$0.78

0.0001 (0.01%)

, CGIX

Cancer Genetics

$2.93

-0.2 (-6.39%)

16:48
11/13/19
11/13
16:48
11/13/19
16:48
Hot Stocks
Interpace Diagnostics changes name to Interpace Biosciences »

Interpace Diagnostics…

IDXG

Interpace Diagnostics

$0.78

0.0001 (0.01%)

CGIX

Cancer Genetics

$2.93

-0.2 (-6.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 07

    Dec

TPTX

Turning Point Therapeutics

$48.68

0.84 (1.76%)

16:46
11/13/19
11/13
16:46
11/13/19
16:46
Initiation
Turning Point Therapeutics initiated  »

Turning Point…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPO

China Biologic

$116.87

1.17 (1.01%)

16:46
11/13/19
11/13
16:46
11/13/19
16:46
Earnings
China Biologic raises FY19 income growth outlook to 11%-13% from 4%-6% »

The company is raising…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CBPO

China Biologic

$116.87

1.17 (1.01%)

16:45
11/13/19
11/13
16:45
11/13/19
16:45
Earnings
China Biologic reports Q3 adjusted EPS $1.40, one estimate 88c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

IDXG

Interpace Diagnostics

$0.78

0.0001 (0.01%)

16:45
11/13/19
11/13
16:45
11/13/19
16:45
Earnings
Breaking Earnings news story on Interpace Diagnostics »

Interpace Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

CSCO

Cisco

$48.44

0.06 (0.12%)

16:45
11/13/19
11/13
16:45
11/13/19
16:45
Hot Stocks
Breaking Hot Stocks news story on Cisco »

Cisco down about 5% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 09

    Dec

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.